Two Thiazide Diuretics Similar for BP Control (CME/CE)
(MedPage Today) -- For older adults with uncomplicated hypertension, neither chlorthalidone nor hydrochlorothiazide had a clear advantage over the other for preventing major adverse events, a retrospective study showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 20, 2013 Category: Cardiology Source Type: news
Cohort study: Chlorthalidone vs. hydrochlorothiazide for the treatment of hypertension
Source: Ann Intern Med
Area: News
The Annals of Internal Medicine has featured a study comparing the effectiveness and safety of chlorthalidone and hydrochlorothiazide for the treatment of hypertension in older adults.
The Canadian propensity score-matched observational cohort study with up to 5 years of follow-up, incorporated data from 29,873 identified individuals aged 66 years or older who were newly treated with chlorthalidone or hydrochlorothiazide and who were not hospitalised for heart failure, stroke, or myocardial infarction in the prior year. Each chlorthalidone recipient was matched to up to 2 hydro...
Source: NeLM - Cardiovascular Medicine - March 19, 2013 Category: Cardiology Source Type: news
enalapril and hydrochlorothiazide, Vaseretic
Title: enalapril and hydrochlorothiazide, VasereticCategory: MedicationsCreated: 4/3/1999 4:02:00 PMLast Editorial Review: 3/8/2013 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - March 8, 2013 Category: Cardiology Source Type: news
CHMP recommends approval of generic telmisartan/hydrochlorothiazide medicines for essential hypertension
Source: European Medicines Agency
Area: News
The Committee for Medicinal Products for Human Use (CHMP) has recommending that the following two generic medicines be approved for the treatment of essential hypertension:
. Actelsar HCT (40mg/12.5 mg, 80mg/12.5 mg and 80mg/25 mg tablets)
. Tolucombi (40mg/12.5 mg, 80mg/12.5 mg and 80mg/25 mg tablets)
The active substances of these medicines are telmisartan (angiotensin II receptor antagonist) and hydrochlorothiazide (thiazide diuretic). Both are generics of MicardisPlus, which has been authorised in the EU since April 2002. Studies ha...
Source: NeLM - Cardiovascular Medicine - January 21, 2013 Category: Cardiology Source Type: news
